IL-31 Inhibitor Improves Atopic Dermatitis

An interleukin-31 inhibitor significantly improved pruritus for patients whose moderate to severe atopic dermatitis did not respond to topical therapy, a phase 2 clinical trial found.
Medscape Medical News

http://ift.tt/2lhiX4P